Imidazo[1,2-a]pyridin-8-ylamine

Catalog No.: 
ACAGZL173
CAS No.: 
73221-18-8
Molecular Formula: 
C7H7N3
Molecular Weight: 
133.15
Imidazo[1,2-a]pyridin-8-ylamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g96%$83.00In stockInquiry
10g96%$157.00In stockInquiry
25g96%$378.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameImidazo[1,2-a]pyridin-8-ylamine
IUPAC Nameimidazo[1,2-a]pyridin-8-amine
MDL No.MFCD06739233
Molecular FormulaC7H7N3
Molecular Weight133.15
SMILESN1=C2[N](C=C1)C=CC=C2N
InChI KeyLKQXJYDAALZCAF-UHFFFAOYSA-N
SynonymCS-W019706 | PB32476 | LKQXJYDAALZCAF-UHFFFAOYSA-N | AMY10779 | Imidazo[1,2-a]pyridin-8-amine | SY110268 | DTXSID60572531 | AKOS006292620 | 8-Amino-imidazo[1,2-a]pyridine | 8-AMINOIMIDAZO[1,2-A]PYRIDINE | H-imidazo[1,2-a]pyridin-8-amine | J-521495 | (1-OX
CAS No.73221-18-8
PubChem CID15413215

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACAGZL173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJFZC504 route compound structure diagram
    ACJFZC504452-58-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAGZL173 route product structure diagram
    ACAGZL17373221-18-8In Stock
Inquiry

2. ACAGZL173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNJQA528 route compound structure diagram
    ACNJQA52852310-46-0In Stock
  2. Then
  3. ACAGZL173 route product structure diagram
    ACAGZL17373221-18-8In Stock
Inquiry

3. ACAGZL173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAGZL173 route product structure diagram
    ACAGZL17373221-18-8In Stock
Inquiry

Comments (0)